Top

Published in:

Open Access 01-12-2014 | Poster presentation

PB.3. Detection of lymph node metastases in newly diagnosed breast cancer patients with axillary ultrasonography in combination with the Memorial Sloan Kettering Cancer Centre normogram as a prediction tool

Authors: CS Low, S Meraj, M Sreenivas

Published in: Breast Cancer Research | Special Issue 1/2014

Excerpt

Current axillary lymph node assessment criteria by ultrasonography (US) depends on cortical thickness >3 mm, focal eccentric cortical thickness and lobulated cortex. Combination with a prediction tool may define better patient management strategies. …

Title: PB.3. Detection of lymph node metastases in newly diagnosed breast cancer patients with axillary ultrasonography in combination with the Memorial Sloan Kettering Cancer Centre normogram as a prediction tool
Authors: CS Low
S Meraj
M Sreenivas
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Breast Cancer Research / Issue Special Issue 1/2014
Electronic ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr3733

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2014

PB.41. What is the incidence of internal mammary node lymphadenopathy on CT in primary breast cancer patients within 1 year of a diagnosis?

Local breast density at lesion sites in diagnostic and previous screening mammograms

PB.38. Extent of agreement between radiological and pathological size and factors affecting completeness of excision in breast-conserving surgery for invasive breast cancer

PB.32. Type of breast surgery in patients undergoing neoadjuvant chemotherapy: role of DCE-MRI

PB.16. Breast screening mammograms: recall or not to recall. What is the golden ratio?

PB.12. Audit and root-cause analysis of classification 2 and 3 interval cancers

Keynote webinar | Spotlight on antibody–drug conjugates in cancer